# CD34+ Selected Stem Cell for Poor Graft Function or Graft Failure

> **NCT06569082** · NA · RECRUITING · sponsor: **NYU Langone Health** · enrollment: 21 (estimated)

## Conditions studied

- Graft Failure
- Poor Graft Function

## Interventions

- **DEVICE:** CD34+ Selected Donor Cell Boost
- **PROCEDURE:** Blood Stem Cell Infusion

## Key facts

- **NCT ID:** NCT06569082
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-31
- **Primary completion:** 2034-08
- **Final completion:** 2035-08
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2025-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06569082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06569082, "CD34+ Selected Stem Cell for Poor Graft Function or Graft Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06569082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*